Inflammasomes in neurological disorders—mechanisms and therapeutic potential

KA Ravichandran, MT Heneka - Nature Reviews Neurology, 2024 - nature.com
Inflammasomes are molecular scaffolds that are activated by damage-associated and
pathogen-associated molecular patterns and form a key element of innate immune …

[HTML][HTML] Malignant glioma remodeling of neuronal circuits: therapeutic opportunities and repurposing of antiepileptic drugs

CN Gonzales, MB Negussie, S Krishna, VS Ambati… - Trends in cancer, 2024 - cell.com
Tumor-associated epilepsy is the most common presenting symptom in patients diagnosed
with diffuse gliomas. Recent evidence illustrates the requirement of synaptic activity to drive …

NLRP1 inflammasome in neurodegenerative disorders: From pathology to therapies

M Zhang, L Yang, Z Li, L Zhou, Y Wang, H Wang… - Cytokine & Growth …, 2024 - Elsevier
Neuroinflammation is a critical component in neurodegenerative disorders. The
inflammasome, facilitates the cleavage of caspase-1, leading to the maturation and …

The NLRP3 inflammasome in neurodegenerative disorders: insights from epileptic models

L Palumbo, M Carinci, A Guarino, L Asth, S Zucchini… - Biomedicines, 2023 - mdpi.com
Neuroinflammation represents a dynamic process of defense and protection against the
harmful action of infectious agents or other detrimental stimuli in the central nervous system …

An explanation of the role of pyroptosis playing in epilepsy

X Zhang, T Zhao, S Su, L Li, Y Zhang, J Yan… - International …, 2024 - Elsevier
Epilepsy is a severe central nervous system disorder characterized by an imbalance
between neuronal excitation and inhibition, resulting in heightened neuronal excitability …

Mechanism of NLRP3 inflammasome in epilepsy and related therapeutic agents

J Chen, Y Gao, N Liu, D Hai, W Wei, Y Liu, X Lan, X Jin… - Neuroscience, 2024 - Elsevier
Epilepsy is one of the most widespread and complex diseases in the central nervous system
(CNS), affecting approximately 65 million people globally, an important factor resulting in …

NLRP3 Inflammasome Inhibitors for Antiepileptogenic Drug Discovery and Development

I Haque, P Thapa, DM Burns, J Zhou… - International Journal of …, 2024 - mdpi.com
Epilepsy is one of the most prevalent and serious brain disorders and affects over 70 million
people globally. Antiseizure medications (ASMs) relieve symptoms and prevent the …

Lipopolysaccharide-induced intestinal inflammation on AIM2-mediated pyroptosis in the brain of rats with cerebral small vessel disease

H Xu, H Xiao, Q Tang - Experimental Neurology, 2024 - Elsevier
Cerebral small vessel disease (CSVD) is a cerebral vascular disease with insidious onset
and poor clinical treatment effect, the disease is related to neuroinflammation. This study …

[HTML][HTML] Ulinastatin modulates NLRP3 inflammasome pathway in PTZ-induced epileptic mice: A potential mechanistic insight

H Wang, Y Ma, D Jin, X Yang, X Xu - Heliyon, 2024 - cell.com
Abstract Objective The NLRP3 (NOD-like receptor family, pyrin domain containing 3)
inflammasome-driven immune-inflammatory response has been shown to play a critical role …

Potential inflammatory mechanisms of the ketogenic diet against febrile infection-related epilepsy syndrome

J Wang, L Xie, L Jiang - Acta Epileptologica, 2025 - Springer
Febrile infection-related epilepsy syndrome (FIRES) is a rare epilepsy syndrome with
unclear pathogenesis, characterized by fever-induced, super-refractory status epilepticus …